US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist

0.3640
-0.0400-9.90%

Close May 10 16:00 ET

0.3699
+0.0059+1.62%

Post 19:56 ET

6.29MMarket Cap-319P/E (TTM)

Theriva Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

12.99%-4.88M

0.45%-19M

-21.85%-6.54M

33.73%-2.95M

10.65%-3.89M

-14.44%-5.61M

-48.04%-19.08M

-11.60%-5.37M

-106.68%-4.46M

-67.80%-4.36M

Net income from continuing operations

-15.34%-5.17M

6.79%-18.35M

14.90%-5.49M

26.48%-3.3M

-13.58%-5.09M

-4.80%-4.48M

-37.97%-19.69M

-22.46%-6.45M

-37.18%-4.49M

-40.13%-4.48M

Depreciation and amortization

21.88%39K

58.82%135K

56.00%39K

33.33%32K

77.78%32K

-2.30%85K

92.31%25K

33.33%24K

-21.74%18K

Deferred tax

32.42%-223K

-15.09%-1.64M

24.01%-424K

-57.31%-527K

32.52%-359K

---330K

---1.43M

---558K

---335K

---532K

Other non cash items

42.86%310K

-188.08%-2M

-154.05%-1.29M

-697.96%-1.47M

234.01%532K

382.22%217K

1,269.88%2.27M

--2.38M

--245K

---397K

Change In working capital

99.83%-2K

386.48%2.31M

152.33%471K

10,447.62%2.17M

-8.38%842K

-46.39%-1.18M

-213.68%-806K

-652.15%-900K

-102.11%-21K

93.88%919K

-Change in prepaid assets

271.36%766K

461.98%1.31M

86.35%-156K

440.84%1.42M

290.63%500K

-214.62%-447K

-308.62%-363K

-929.73%-1.14M

423.46%262K

-68.63%128K

-Change in payables and accrued expense

-3.65%-653K

544.20%1.42M

207.08%737K

435.80%863K

-46.98%447K

44.98%-630K

-142.48%-319K

-46.07%240K

-123.73%-257K

994.81%843K

-Change in other current liabilities

-15.00%-115K

-240.32%-422K

-3,766.67%-110K

-311.54%-107K

-101.92%-105K

-104.08%-100K

42.59%-124K

106.25%3K

44.68%-26K

1.89%-52K

Cash from discontinued investing activities

Operating cash flow

12.99%-4.88M

0.45%-19M

-21.85%-6.54M

33.73%-2.95M

10.65%-3.89M

-14.44%-5.61M

-48.04%-19.08M

-11.60%-5.37M

-106.68%-4.46M

-67.80%-4.36M

Investing cash flow

Cash flow from continuing investing activities

95.40%-202K

38.46%-56K

-1,072.73%-129K

35.71%-9K

99.81%-8K

-31,300.00%-4.4M

-91K

-11K

-14K

Net PPE purchase and sale

--0

-74.14%-202K

38.46%-56K

-1,072.73%-129K

35.71%-9K

---8K

-728.57%-116K

---91K

---11K

---14K

Net business purchase and sale

----

--0

----

---4.28M

--0

Cash from discontinued investing activities

Investing cash flow

--0

95.40%-202K

38.46%-56K

-1,072.73%-129K

35.71%-9K

99.81%-8K

-31,300.00%-4.4M

---91K

---11K

---14K

Financing cash flow

Cash flow from continuing financing activities

132.38%625K

55.69%-1.46M

-99.96%1K

2.14M

96.00%-55K

-102.61%-1.93M

-3.29M

2.73M

Net issuance payments of debt

--0

94.55%-75K

--0

---20K

96.00%-55K

---1.38M

--0

Net common stock issuance

----

870.49%2.22M

121.53%62K

--1K

----

-100.44%-288K

---288K

--0

----

Net preferred stock issuance

----

--0

----

--2.73M

--0

----

Net other financing activities

----

49.37%-1.52M

----

---3M

----

Cash from discontinued financing activities

Financing cash flow

--0

132.38%625K

55.69%-1.46M

-99.96%1K

--2.14M

96.00%-55K

-102.61%-1.93M

---3.29M

--2.73M

--0

Net cash flow

Beginning cash position

-44.42%23.28M

-37.79%41.89M

-38.20%31.26M

-34.40%34.35M

-36.30%36.18M

-37.79%41.88M

981.18%67.33M

-29.88%50.58M

-29.52%52.36M

-26.13%56.8M

Current changes in cash

13.96%-4.88M

26.90%-18.57M

7.92%-8.05M

-77.78%-3.08M

59.61%-1.77M

46.27%-5.67M

-141.59%-25.41M

-81.85%-8.75M

19.62%-1.73M

-68.34%-4.37M

Effect of exchange rate changes

-8.57%-38K

-3.13%-33K

46.15%76K

77.55%-11K

0.00%-63K

-225.00%-35K

---32K

--52K

---49K

---63K

End cash Position

-49.25%18.36M

-44.42%23.28M

-38.20%31.26M

-34.40%34.35M

-36.30%36.18M

-37.79%41.89M

-29.88%50.58M

-29.52%52.36M

Free cash flow

13.12%-4.88M

0.00%-19.2M

-20.85%-6.6M

31.01%-3.08M

10.73%-3.9M

-14.61%-5.62M

-48.78%-19.2M

-13.49%-5.46M

-107.19%-4.47M

-68.34%-4.37M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	12.99%-4.88M	0.45%-19M	-21.85%-6.54M	33.73%-2.95M	10.65%-3.89M	-14.44%-5.61M	-48.04%-19.08M	-11.60%-5.37M	-106.68%-4.46M	-67.80%-4.36M
Net income from continuing operations	-15.34%-5.17M	6.79%-18.35M	14.90%-5.49M	26.48%-3.3M	-13.58%-5.09M	-4.80%-4.48M	-37.97%-19.69M	-22.46%-6.45M	-37.18%-4.49M	-40.13%-4.48M
Depreciation and amortization	21.88%39K	58.82%135K	56.00%39K	33.33%32K	77.78%32K	77.78%32K	-2.30%85K	92.31%25K	33.33%24K	-21.74%18K
Deferred tax	32.42%-223K	-15.09%-1.64M	24.01%-424K	-57.31%-527K	32.52%-359K	---330K	---1.43M	---558K	---335K	---532K
Other non cash items	42.86%310K	-188.08%-2M	-154.05%-1.29M	-697.96%-1.47M	234.01%532K	382.22%217K	1,269.88%2.27M	--2.38M	--245K	---397K
Change In working capital	99.83%-2K	386.48%2.31M	152.33%471K	10,447.62%2.17M	-8.38%842K	-46.39%-1.18M	-213.68%-806K	-652.15%-900K	-102.11%-21K	93.88%919K
-Change in prepaid assets	271.36%766K	461.98%1.31M	86.35%-156K	440.84%1.42M	290.63%500K	-214.62%-447K	-308.62%-363K	-929.73%-1.14M	423.46%262K	-68.63%128K
-Change in payables and accrued expense	-3.65%-653K	544.20%1.42M	207.08%737K	435.80%863K	-46.98%447K	44.98%-630K	-142.48%-319K	-46.07%240K	-123.73%-257K	994.81%843K
-Change in other current liabilities	-15.00%-115K	-240.32%-422K	-3,766.67%-110K	-311.54%-107K	-101.92%-105K	-104.08%-100K	42.59%-124K	106.25%3K	44.68%-26K	1.89%-52K
Cash from discontinued investing activities
Operating cash flow	12.99%-4.88M	0.45%-19M	-21.85%-6.54M	33.73%-2.95M	10.65%-3.89M	-14.44%-5.61M	-48.04%-19.08M	-11.60%-5.37M	-106.68%-4.46M	-67.80%-4.36M
Investing cash flow
Cash flow from continuing investing activities	0	95.40%-202K	38.46%-56K	-1,072.73%-129K	35.71%-9K	99.81%-8K	-31,300.00%-4.4M	-91K	-11K	-14K
Net PPE purchase and sale	--0	-74.14%-202K	38.46%-56K	-1,072.73%-129K	35.71%-9K	---8K	-728.57%-116K	---91K	---11K	---14K
Net business purchase and sale	----	--0	--0	--0	----	----	---4.28M	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	95.40%-202K	38.46%-56K	-1,072.73%-129K	35.71%-9K	99.81%-8K	-31,300.00%-4.4M	---91K	---11K	---14K
Financing cash flow
Cash flow from continuing financing activities	0	132.38%625K	55.69%-1.46M	-99.96%1K	2.14M	96.00%-55K	-102.61%-1.93M	-3.29M	2.73M	0
Net issuance payments of debt	--0	94.55%-75K	--0	--0	---20K	96.00%-55K	---1.38M	--0	--0	--0
Net common stock issuance	----	870.49%2.22M	121.53%62K	--1K	----	----	-100.44%-288K	---288K	--0	----
Net preferred stock issuance	----	--0	--0	----	----	----	--2.73M	--0	----	----
Net other financing activities	----	49.37%-1.52M	----	----	----	----	---3M	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	132.38%625K	55.69%-1.46M	-99.96%1K	--2.14M	96.00%-55K	-102.61%-1.93M	---3.29M	--2.73M	--0
Net cash flow
Beginning cash position	-44.42%23.28M	-37.79%41.89M	-38.20%31.26M	-34.40%34.35M	-36.30%36.18M	-37.79%41.88M	981.18%67.33M	-29.88%50.58M	-29.52%52.36M	-26.13%56.8M
Current changes in cash	13.96%-4.88M	26.90%-18.57M	7.92%-8.05M	-77.78%-3.08M	59.61%-1.77M	46.27%-5.67M	-141.59%-25.41M	-81.85%-8.75M	19.62%-1.73M	-68.34%-4.37M
Effect of exchange rate changes	-8.57%-38K	-3.13%-33K	46.15%76K	77.55%-11K	0.00%-63K	-225.00%-35K	---32K	--52K	---49K	---63K
End cash Position	-49.25%18.36M	-44.42%23.28M	-44.42%23.28M	-38.20%31.26M	-34.40%34.35M	-36.30%36.18M	-37.79%41.89M	-37.79%41.89M	-29.88%50.58M	-29.52%52.36M
Free cash flow	13.12%-4.88M	0.00%-19.2M	-20.85%-6.6M	31.01%-3.08M	10.73%-3.9M	-14.61%-5.62M	-48.78%-19.2M	-13.49%-5.46M	-107.19%-4.47M	-68.34%-4.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall